EGFR and adenocarcinoma: Concerning the findings of the present study, 1 adenocarcinoma patient was found to carry both EGFR activating c.2573T>G and inhibiting c.2369C>T mutations following analysis of material isolated via the FNA procedure, indicating that the mutations were of activating and inhibiting types, respectively.